CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Candida - female genital - Management
Quick answers
- Scenario: Uncomplicated infection: covers the management of women presenting with an uncomplicated isolated episode of vulvovaginal candidiasis, and how to manage treatment failure. Uncomplicated vulvovaginal candidiasis is defined as:
- Sporadic or infrequent, and
- Mild to moderate, and
- Likely to be due to Candida albicans, and
- NOT associated with risk factors such as pregnancy, poorly controlled diabetes, compromised immunity, and debilitation.
- Scenario: Severe infection: covers the management of women presenting with severe vulvovaginal candidiasis (i.e. with extensive vulvar erythema, oedema, excoriation, and fissure formation), and how to manage treatment failure.
- Scenario: Recurrent infection: covers the management of women suffering from recurrent vulvovaginal candidiasis (i.e. four or more episodes in a year).
- Scenario: During pregnancy: covers the management of women who are pregnant and have vulvovaginal candidiasis, and how to manage treatment failure.
- Scenario: Diabetes or immunocompromised: covers the management of vulvovaginal candidiasis in women who have poorly controlled diabetes mellitus, or who are immunocompromised.
© NHS Institute for Innovation and Improvement